screen
main
proteas
middl
east
respiratori
syndrom
papainlik
proteas
proteas
matur
sever
acut
respiratori
syndrom
structurebas
inhibitor
design
correspond
r
hilgenfeld
review
focus
import
contribut
macromolecular
crystallographi
made
past
year
elucid
structur
mechan
essenti
proteas
coronavirus
main
proteas
pro
papainlik
proteas
pl
pro
role
xray
crystallographi
structureassist
drug
discoveri
target
discuss
aspect
dealt
review
includ
emerg
sar
coronaviru
mer
coronaviru
year
later
origin
virus
crystal
structur
free
sar
coronaviru
pro
depend
ph
discuss
effort
design
inhibitor
basi
structur
mechan
matur
enzym
viral
polyprotein
still
matter
debat
crystal
structur
sar
coronaviru
pl
pro
complex
ubiquitin
also
discuss
orthologu
mer
coronaviru
effort
predict
structurebas
inhibitor
develop
bat
coronaviru
pro
increas
prepared
zoonot
transmiss
man
describ
well
paper
close
brief
discuss
structurebas
discoveri
antivir
academ
set
call
group
coronavirus
time
accord
new
nomenclatur
introduc
year
later
see
exampl
sarscov
belong
clade
b
genu
betacoronaviru
newli
discov
newli
emerg
human
coronavirus
follow
sar
epidem
two
new
human
coronavirus
discov
due
intensifi
research
effort
target
previous
neglect
viru
famili
human
coronaviru
member
genu
alphacoronaviru
describ
follow
discoveri
hcov
cladea
betacoronaviru
year
later
virus
widespread
caus
sever
diseas
major
peopl
infect
septemb
anoth
novel
human
coronaviru
middl
east
respiratori
syndrom
mer
coronaviru
describ
detect
patient
saudi
arabia
countri
arab
peninsula
peopl
histori
travel
middl
east
earliest
cluster
mer
case
detect
far
jordan
april
shown
retrospect
basi
patient
sampl
symptom
mer
includ
sever
respiratori
diseas
often
renal
failur
juli
laboratoryconfirm
case
record
death
http
wwwwhoint
casefat
ratio
mer
thu
alarmingli
high
sar
mer
coronavirus
come
case
sarscov
wild
anim
palm
civet
sold
delicaci
chines
wet
market
initi
identifi
immedi
sourc
viru
insectivor
rhinolophid
bat
came
focu
origin
reservoir
viru
possibl
transmit
civet
market
speci
human
see
recent
review
bat
coronavirus
howev
took
discov
bat
coronaviru
ident
sarscov
use
receptor
surfac
host
cell
angiotensinconvert
enzym
case
mer
coronaviru
merscov
bat
suspect
reservoir
coronavirus
high
sequenc
similar
merscov
discov
african
european
bat
recent
month
pictur
chang
somewhat
dromedari
camel
main
suspect
reservoir
zoonot
transmiss
human
popul
origin
sar
epidem
mani
scientist
policymak
includ
even
mani
virologist
believ
event
uniqu
chanc
repetit
extrem
low
thu
must
said
effort
could
made
develop
smallmolecul
compound
anticoronaviru
activ
hamper
howev
sharp
declin
fund
coronaviru
research
mani
countri
lack
support
scientif
commun
consequ
lesson
sar
outbreak
taught
us
taken
serious
discuss
recentand
still
continuingemerg
merscov
illustr
event
happen
anywher
time
given
larg
number
coronaviru
speci
natur
probabl
know
fraction
far
coronavirus
featur
largest
rna
genom
kb
fig
known
genom
extrem
flexibl
term
incorpor
delet
gene
product
respons
evolutionari
pressur
need
adapt
new
host
coronaviru
genom
also
prone
recombin
event
therebi
ad
flexibl
review
illumin
question
whether
macromolecular
crystallographi
contribut
discoveri
antivir
target
protein
new
virus
sarscov
merscov
focu
main
antivir
drug
target
coronaviru
main
proteas
pro
also
call
proteas
pro
papainlik
proteas
pl
pro
enzym
coronavirus
helicas
rnadepend
rna
polymeras
also
target
antivir
drug
discoveri
effort
limit
far
lack
crystal
occupi
twothird
genom
end
openread
frame
encod
two
larg
polyprotein
ribosom
frameshift
translat
polyprotein
process
matur
nsp
two
proteas
discuss
indic
yellow
main
proteas
pro
also
call
proteas
pro
wherea
papainlik
proteas
pl
pro
part
pl
pro
perform
three
cleavag
reaction
red
arrow
releas
red
wherea
pro
cleav
polyprotein
site
cyan
arrow
releas
cyan
termin
third
genom
code
structur
accessori
protein
structur
enzym
see
recent
review
coronavir
proteas
pro
pl
pro
respons
process
huge
polyprotein
encod
open
read
frame
coronaviru
genom
matur
nonstructur
protein
nsp
form
part
coronavir
replicationtranscript
complex
fig
inform
sarscov
protein
structur
see
pro
encod
nonstructur
protein
respons
less
cleavag
site
polyprotein
fig
flank
protein
along
part
anchor
replicationtranscript
complex
doublemembran
vesicl
deriv
endoplasm
reticulum
membran
infect
substrat
cleavag
pro
follow
gener
pattern
small
x
lfm
ga
x
x
amino
acid
cleavag
site
particular
glutamin
q
residu
posit
substrat
absolut
requir
hostcel
proteas
known
specif
prospect
come
anticoronavir
without
mani
sideeffect
actual
good
crystallograph
studi
coronaviru
pro
prior
sar
outbreak
group
start
work
coronaviru
pro
around
time
singl
crystal
structur
coronaviru
protein
determin
first
elucid
crystal
structur
pro
transmiss
gastroenter
viru
tgev
porcin
coronaviru
fatal
young
piglet
publish
structur
reveal
pro
dimer
cf
fig
nterminu
nfinger
one
monom
help
shape
substratespecif
pocket
oxyanion
hole
monom
henc
dimer
prerequisit
catalyt
activ
also
reveal
presenc
ahel
domain
domain
iii
addit
domain
ii
togeth
featur
chymotrypsinlik
fold
harbor
catalyt
cy
dyad
subsequ
synthes
chloromethylketon
inhibitor
cocrystal
tgev
pro
order
visual
substratebind
site
detail
time
also
determin
structur
pro
human
coronaviru
hcov
sarscov
identifi
sequenc
spring
built
first
homolog
model
sarscov
pro
basi
structur
enzym
hcov
suggest
basi
bind
mode
chloromethylketon
inhibitor
michael
acceptor
compound
rupintrivir
develop
pfizer
inhibitor
proteas
human
rhinoviru
good
start
point
antisar
drug
design
later
compound
turn
particularli
high
activ
sarscov
cell
cultur
deriv
michael
acceptor
lead
turn
exhibit
good
anticoronavir
activ
vitro
ex
vivo
toward
end
sar
outbreak
beij
june
crystal
structur
sarscov
main
proteas
determin
collabor
group
zihe
rao
beij
recombinantli
produc
crystal
enzym
group
free
proteas
fig
complex
chloromethylketon
inhibitor
alreadi
use
tgev
pro
catalyt
dyad
subunit
indic
nand
ctermini
note
nterminu
cyan
polypeptid
chain
locat
close
substratebind
site
purpl
subunit
first
structur
free
sarscov
pro
determin
crystal
grown
acid
ph
around
structur
one
monom
pro
dimer
activ
state
one
catalyt
incompet
conform
specif
pocket
oxyanion
hole
collaps
crystal
equilibr
buffer
ph
monom
found
activ
conform
wherea
ph
substratebind
site
less
well
defin
due
increas
flexibl
amino
acid
sidechain
involv
phenomenon
explain
molecular
dynam
simul
run
differ
proton
state
two
key
histidin
residu
involv
shape
substratebind
site
phactiv
profil
sarscov
pro
found
probabl
determin
proton
inactiv
acid
ph
deproton
inactiv
basic
ph
observ
catalyt
incompet
form
site
oxyanion
hole
collaps
occasion
ascrib
eg
presenc
five
addit
residu
nterminu
remain
clone
procedur
phenomenon
observ
enzym
featur
authent
chain
termini
crystal
space
group
determin
structur
sarscov
pro
authent
chain
termini
crystal
grown
symmetri
observ
presenc
activ
inact
monom
low
ph
verschueren
et
al
unpublish
exist
less
activ
proform
enzym
may
allow
control
tempor
order
process
individu
polyprotein
cleavag
site
releas
intermedi
matur
nsp
time
replic
need
unfortun
ph
site
action
pro
endoplasmicreticulumderiv
doublemembran
vesicl
known
autoactiv
liber
viral
polyprotein
pro
integr
part
polyprotein
fig
mechan
autoactiv
enzym
well
understood
see
review
sever
studi
use
construct
carri
fluoresc
protein
termini
sarscov
pro
connect
enzym
peptid
sequenc
contain
pro
cleavag
site
polyprotein
model
usual
monomer
dimer
format
upon
addit
substrat
observ
found
upon
mutat
three
residu
involv
monomermonom
interfac
matur
proteas
result
monomer
enzym
still
perform
ntermin
autocleavag
dimer
transcleavag
activ
complet
inhibit
mutat
partli
mutat
furthermor
matur
mutant
resum
ntermin
autocleavag
activ
mix
inact
pro
speci
wherea
transcleavag
activ
remain
absent
therefor
ntermin
autoprocess
pro
appear
requir
two
immatur
monom
approach
one
anoth
form
intermedi
dimer
structur
depend
activ
dimer
conform
exist
matur
proteas
octamer
form
immatur
pro
featur
threedimension
swap
helic
domain
iii
enzym
may
play
role
autoactiv
process
larg
number
crystal
structur
publish
inhibitor
complex
sarscov
pro
mention
mani
type
chemic
warhead
use
achiev
coval
bind
peptid
peptidomimet
inhibitor
activesit
cystein
pro
includ
halomethylketon
michael
acceptor
compound
bunsatur
ester
mention
aldehyd
bepoxyketon
nitril
phthalhydrazid
keton
compound
peptidomimet
carri
electrophil
warhead
sever
also
effici
inhibit
sarscov
replic
cell
cultur
inhibitor
exampl
halomethylketon
certainli
reactiv
develop
drug
expect
exhibit
consider
sideeffect
one
might
intuit
assum
aldehyd
fact
peptid
aldehyd
inhibitor
thrombin
efegatran
show
toxic
clinic
trial
also
note
two
hepat
c
viru
proteas
inhibitor
introduc
market
telaprivir
boceprivir
peptidomimet
carri
aketoamid
warhead
final
rupintrivir
exampl
michael
acceptor
compound
develop
inhibitor
proteas
human
rhinoviru
trend
away
noncoval
binder
target
serin
cystein
proteas
toward
coval
revers
irrevers
binder
given
absolut
requir
coronaviru
pro
glutamin
posit
substrat
absenc
human
proteas
specif
good
chanc
develop
coronaviru
proteas
inhibitor
carri
electrophil
warhead
without
expect
mani
sideeffect
see
figur
show
bind
broadspectrum
michael
acceptor
compound
origin
develop
enteroviru
proteas
complex
sarscov
pro
reveal
xray
crystallographi
addit
number
nonpeptid
revers
inhibitor
main
proteas
discov
virtual
screen
andor
dock
basi
crystal
structur
exampl
compound
cinanserin
arylboron
acid
isatin
deriv
select
diarylsulfon
varieti
other
nonpeptid
inhibitor
benzotriazol
ester
nonwarhead
benzo
triazol
discov
screen
chemic
librari
subsequ
optim
hit
medicin
chemistri
chloropyridyl
ester
deriv
benzotriazol
ester
found
good
antivir
activ
cell
cultur
proteas
encod
sarscov
genom
papainlik
proteas
respons
process
three
cleavag
site
ntermin
part
polyprotein
produc
matur
fig
cleavag
specif
pl
pro
correspond
pattern
rk
l
rk
addit
enzym
deubiquitinas
ie
remov
poli
ubiquitin
unit
protein
tag
ubiquitin
carri
sequenc
lrlrgg
cterminu
perfect
agreement
coronaviru
pl
pro
recognit
motif
deubiquitinas
activ
enzym
interfer
asyet
unknown
way
phosphoryl
nuclear
import
interferonregulatori
factor
therebi
prevent
product
typei
interferon
infect
host
cell
sarscov
pl
pro
also
shown
activ
ie
remov
unit
target
protein
label
way
isg
interferonstimul
gene
product
final
sarscov
pl
pro
demonstr
interfer
nuclear
factor
jb
pathway
ie
import
weapon
viru
effort
counteract
innat
immun
respons
infect
host
cell
crystal
structur
sarscov
pl
pro
report
ratia
et
al
enzym
consist
ntermin
ubiquitinlik
ubl
domain
catalyt
core
domain
featur
openrighthand
fold
thumb
palm
finger
subdomain
tip
finger
domain
structur
zinc
ion
found
within
zincribbon
structur
fig
took
number
year
obtain
crystallin
complex
sarscov
pl
pro
ubiquitin
recent
chou
et
al
publish
structur
complex
ubiquitin
pl
pro
catalyt
cystein
residu
replac
serin
ratia
et
al
report
structur
nativ
sarscov
pl
pro
complex
ubiquitin
aldehyd
ctermin
aldehyd
group
form
coval
bond
catalyt
enzym
use
peptidomimet
inhibitor
block
sarscov
pl
pro
connect
difficulti
inhibitor
would
like
also
inhibit
hostcel
deubiquitinas
sever
sideeffect
would
expect
therefor
search
inhibitor
sarscov
pl
pro
focus
screen
chemic
librari
nonpeptid
revers
inhibitor
enzym
way
ratia
et
al
ghosh
et
al
identifi
hit
compound
optim
yield
inhibitor
submicromolar
activ
isol
enzym
lowmicromolar
activ
sarscovinfect
cell
cultur
see
also
hittolead
optim
reli
heavili
crystal
structur
complex
select
candid
inhibitor
sarscov
pl
pro
sever
inhibitor
discov
way
eg
bind
directli
catalyt
site
proteas
near
site
spaciou
restrict
site
accommod
exclus
glycin
residu
substrat
ie
viral
polyprotein
ubiquitin
figur
show
inhibitor
spacefil
present
bound
site
far
catalyt
triad
cyan
stick
crystallograph
inhibitor
discoveri
studi
bat
coronaviru
pro
increas
prepared
zoonot
transmiss
evid
grow
zoonot
transmiss
sarscov
bat
via
intermedi
host
human
start
get
interest
bat
coro
fig
structur
sarscov
pl
pro
complex
nonpeptid
inhibitor
domain
enzym
indic
color
follow
yellow
ubiquitinlik
ubl
domain
pink
thumb
domain
blue
palm
domain
cyan
finger
domain
zinc
ion
bound
tip
finger
domain
color
red
inhibitor
spacefil
present
carbon
grey
nitrogen
blue
oxygen
red
bind
site
far
catalyt
triad
cyan
stick
naviru
main
proteas
drug
target
obvious
goal
cure
bat
coronaviru
infect
reservoir
bat
show
sign
diseas
carri
coronavirus
want
design
inhibitor
enzym
readi
case
zoonot
transmiss
bat
coronaviru
human
popul
idea
design
synthes
one
lead
compound
broadspectrum
anticoronavir
activ
immedi
enter
preclin
develop
case
major
epidem
outset
project
select
three
bat
coronavirus
repres
coronaviru
famili
btcov
alphacoronaviru
btcov
betacoronaviru
clade
c
betacoronaviru
clade
pdb
code
notic
abovement
broadspectrum
antivir
michael
acceptor
compound
inhibit
enzym
proofofprincipl
predict
approach
came
merscov
emerg
found
inde
good
inhibitor
viru
cell
cultur
xiao
de
wild
muth
et
al
publish
btcov
turn
close
rel
merscov
amino
acid
sequenc
ident
similar
main
proteas
inact
pro
howev
also
suggest
inhibitor
becom
broad
spectrum
present
ideal
one
would
like
one
broadspectrum
antivir
hand
would
efficaci
coronaviru
famili
modif
good
activ
alphacoronavirus
develop
laboratori
sarscov
main
proteas
pro
pro
papainlik
proteas
pl
pro
prime
target
develop
antivir
newli
emerg
merscov
threedimension
structur
describ
pro
shortli
discoveri
new
viru
unfortun
atom
coordin
deposit
protein
data
bank
public
describ
sarscov
pro
inhibitor
michael
acceptor
compound
good
inhibitor
merscov
pro
structur
papainlik
proteas
new
viru
also
determin
enzym
featur
signific
differ
sarscov
pl
pro
thu
stabil
oxyanion
intermedi
proteolyt
reaction
catalyz
merscov
pl
pro
appear
differ
mechan
propos
sarscov
pl
pro
papainlik
proteas
oxyanion
commonli
stabil
two
hydrogen
bond
enzym
one
donat
mainchain
amid
catalyt
residu
glutamin
asparagin
sidechain
five
six
residu
ntermin
catalyt
cystein
sarscov
pl
pro
correspond
sidechain
propos
donat
hydrogen
bond
oxyanion
indol
nitrogen
merscov
pl
pro
tryptophan
replac
lack
hydrogenbond
capabl
interestingli
mutat
merscov
pl
pro
increas
peptidolyt
deubiquitin
activ
enzym
factor
respect
indic
proteas
optim
maximum
activ
evolut
viru
differ
sarscov
pl
pro
merscov
pl
pro
includ
specif
subsit
subsit
accommod
arginin
residu
ubiquitin
sarscov
pl
proubiquitin
complex
arginin
lysin
pl
pro
cleavag
site
viral
polyprotein
accordingli
subsit
domin
neg
charg
amino
acid
sidechain
sarscov
enzym
ie
site
site
howev
merscov
pl
pro
latter
residu
replac
posit
charg
henc
direct
extrapol
structur
sarscov
pl
pro
ubiquitin
complex
ubiquitin
recognit
merscov
enzym
possibl
rather
crystal
structur
complex
await
respons
crystallograph
commun
sar
outbreak
occasion
describ
swift
howev
realist
note
determin
structur
tgev
pro
includ
inhibitor
complex
prior
sar
outbreak
respons
would
probabl
significantli
slower
nevertheless
hope
abl
review
illustr
import
role
play
xray
crystallographi
elucid
threedimension
structur
two
import
target
discoveri
develop
anticoronaviru
drug
main
proteas
pro
papainlik
proteas
pl
pro
fact
peptidomimet
inhibitor
pro
design
basi
structur
knowledg
enzym
wherea
sever
nonpeptid
inhibitor
identifi
use
crystal
structur
target
virtual
screen
chemic
librari
known
inhibitor
pl
pro
hand
mostli
base
origin
hit
identifi
highthroughput
screen
virtual
screen
campaign
recombin
enzym
subsequ
optim
accord
dock
sarscov
pl
pro
crystal
structur
complex
target
howev
none
compound
direct
coronaviru
proteas
gone
complet
preclin
develop
program
mainli
sharp
declin
fund
countri
nonetheless
inhibitor
describ
far
good
start
point
develop
case
futur
zoonot
transmiss
coronavirus
human
popul
case
continu
mer
outbreak
occasion
argu
drug
discoveri
remain
domain
pharmaceut
industri
prioriti
academia
former
undoubtedli
better
howev
realiz
big
pharma
gener
littl
interest
emerg
rna
virus
typic
caus
selflimit
rather
chronic
diseas
yet
virus
potenti
pose
big
threat
man
impress
taught
sar
coronaviru
well
advis
increas
prepared
view
increas
frequenc
outbreak
caus
virus
academ
institut
import
task
effort
increas
prepared
far
preclin
discoveri
phase
drug
develop
process
concern
macromolecular
crystallographi
undoubtedli
continu
play
major
role
effort
